| 1 |
31307539 |
10.1186/s40425-019-0664-3 |
2019 |
Molecular and metabolic pathways mediating curative treatment of a non-Hodgkin B cell lymphoma by Sindbis viral vectors and anti-4-1BB monoclonal antibody. |
TNFSF9 |
| 2 |
30194255 |
10.1182/blood-2018-04-845834 |
2018 |
Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma. |
TNFSF9 |
| 3 |
27756788 |
10.1158/1078-0432.CCR-16-1272 |
2017 |
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody. |
TNFSF9 |
| 4 |
25710169 |
10.1371/journal.ppat.1004652 |
2015 |
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma-associated herpesvirus ORF57 protein and host pre-mRNA metabolism. |
TNFSF9 |
| 5 |
23095505 |
10.1097/PAS.0b013e318268c6ea |
2013 |
CD137 ligand is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications. |
TNFSF9 |
| 6 |
23204227 |
10.1158/0008-5472.CAN-12-3849 |
2013 |
Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression. |
TNFSF9 |
| 7 |
23716461 |
10.1002/gcc.22072 |
2013 |
The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma. |
TNFSF9 |
| 8 |
22213068 |
10.1002/ijc.27416 |
2012 |
Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas. |
TNFSF9 |
| 9 |
20438785 |
10.1016/j.humimm.2010.04.004 |
2010 |
Polymorphisms in innate immunity genes and risk of childhood leukemia. |
TNFSF9 |
| 10 |
20520765 |
10.1371/journal.pone.0010845 |
2010 |
Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling. |
TNFSF9 |
| 11 |
19225975 |
10.1080/10428190802709453 |
2009 |
The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders. |
TNFSF9 |
| 12 |
19382019 |
10.1080/09553000902838541 |
2009 |
Effect of (211)At alpha-particle irradiation on expression of selected radiation responsive genes in human lymphocytes. |
TNFSF9 |
| 13 |
19573080 |
10.1111/j.1365-2141.2009.07790.x |
2009 |
Common genetic variants in candidate genes and risk of familial lymphoid malignancies. |
TNFSF9 |
| 14 |
19608748 |
10.1182/blood-2009-03-208215 |
2009 |
Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma. |
TNFSF9 |
| 15 |
19773279 |
10.1136/oem.2008.044024 |
2009 |
Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. |
TNFSF9 |
| 16 |
16287062 |
10.1002/ijc.21579 |
2006 |
Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival. |
TNFSF9 |
| 17 |
16800841 |
10.1111/j.1600-0609.2006.00679.x |
2006 |
Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma. |
TNFSF9 |
| 18 |
14648705 |
10.1002/ijc.11574 |
2004 |
CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival. |
TNFSF9 |
| 19 |
11485353 |
10.1006/cimm.2001.1804 |
2001 |
4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors. |
TNFSF9 |
| 20 |
10202049 |
|
1999 |
4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine. |
TNFSF9 |
| 21 |
7532686 |
10.1084/jem.181.3.985 |
1995 |
Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. |
TNFSF9 |
| 22 |
7622190 |
10.1016/0165-2478(94)00227-i |
1995 |
Characterization of human homologue of 4-1BB and its ligand. |
TNFSF9 |
Datasets
Models
